Genelux (NASDAQ:GNLX) reported quarterly losses of $(0.21) per share which missed the analyst consen

-- Topline data from Phase 3 OnPrime/GOG-3076 ovarian cancer registrational trial  of Olvi-Vec expec

Genelux (NASDAQ: GNLX - Get Free Report) is expected to post its Q2 2026 results before the market o

- Findings provide mechanistic support for previously reported clinical outcomes of clinical reversa

- Findings provide mechanistic support for previously reported clinical outcomes of clinical reversa

-- Topline data from randomized Phase 3 OnPrime/GOG-3076 ovarian cancer registrational trial of Olvi

Benchmark analyst Bruce D. Jackson maintains Genelux (NASDAQ:GNLX) with a Speculative Buy and low

Genelux (NASDAQ:GNLX) reported quarterly losses of $(0.24) per share which missed the analyst consen

-- Topline data from Phase 3 OnPrime/GOG-3076 ovarian cancer registrational trial of Olvi-Vec expect

WESTLAKE VILLAGE, Calif., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Genelux Corporation (NASDAQ: GNLX), a la

WESTLAKE VILLAGE, Calif., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Genelux Corporation (“Genelux”) (Nasdaq:

WESTLAKE VILLAGE, Calif., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Genelux Corporation (“Genelux”) (Nasdaq:

WESTLAKE VILLAGE, Calif., Jan. 02, 2026 (GLOBE NEWSWIRE) --  Genelux Corporation (NASDAQ: GNLX), a l

-- Lung cancer programs progressing with interim data updates expected in Q4 2025 -- -- Topline data

WESTLAKE VILLAGE, Calif., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Genelux Corporation (NASDAQ: GNLX), a la

WESTLAKE VILLAGE, Calif., July 07, 2025 (GLOBE NEWSWIRE) -- Genelux Corporation (NASDAQ: GNLX), a la

Genelux Corporation (GNLX) might move higher on growing optimism about its earnings prospects, which

WESTLAKE VILLAGE, Calif., May 06, 2025 (GLOBE NEWSWIRE) -- Genelux Corporation (NASDAQ: GNLX), a lat

– Alignment reached with U.S. Food and Drug Administration on key elements of the approval pathway f

Genelux Corporation (GNLX) is technically in oversold territory now, so the heavy selling pressure m

WESTLAKE VILLAGE, Calif., March 25, 2025 (GLOBE NEWSWIRE) -- Genelux Corporation (“Genelux”) (Nasdaq

WESTLAKE VILLAGE, Calif., Feb. 03, 2025 (GLOBE NEWSWIRE) -- Genelux Corporation (NASDAQ: GNLX), a la

WESTLAKE VILLAGE, Calif., Dec. 13, 2024 (GLOBE NEWSWIRE) -- Genelux Corporation (NASDAQ: GNLX), a la

WESTLAKE VILLAGE, Calif., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Genelux Corporation (NASDAQ: GNLX), a la

Shares of Quanex Building Products Corporation (NYSE: NX) moved lower during Friday’s session after

Shares of Daktronics, Inc. (NASDAQ: DAKT) moved lower during Tuesday’s session following weak quarte

Shares of ReNew Energy Global Plc (NASDAQ: RNW) gained during Monday’s session following strong quar

Gainers Apollomics, Inc. (NASDAQ: APLM) shares surged 88.4% to $1.07 stoma multiforme with PTPRZ

U.S. stocks traded higher, with the Dow Jones gaining around 150 points on Tuesday. Here are some bi

U.S. stocks traded down this morning, with the Nasdaq Composite falling more than 101 points on Frid

Gainers Amyris, Inc. (NASDAQ: AMRS) shares jumped 179.1% to $0.1839. Amyris shares dipped over 8

Gainers Unique Fabricating, Inc. (NYSE: UFAB) shares jumped 113% to $0.4605 after gaining 12% on

Gainers Aurora Acquisition Corp. (NASDAQ: AURC) shares jumped 192% to $30.54.

In a year that’s seen a sharp decline in initial public offerings, Washington, D.C.-based Mediterran

Gainers Lipella Pharmaceuticals Inc. (NASDAQ: LIPO) shares jumped 40.2% to $2.5109 after the comp

U.S. stocks traded lower, with the Dow Jones dropping more than 250 points on Thursday. Here are som

Gainers Virax Biolabs Group Limited (NASDAQ: VRAX) jumped 99% to $1.3195 after the company announ